Pasithea Therapeutics Corp.
KTTA
$0.57
-$0.03-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.27M | -2.87M | -10.11M | -3.04M | -3.72M |
| Total Depreciation and Amortization | 157.50K | 157.50K | 157.50K | 181.60K | 161.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 309.30K | -1.40M | 4.67M | 109.00K | 66.50K |
| Change in Net Operating Assets | 99.50K | -672.30K | -111.30K | -143.20K | -380.30K |
| Cash from Operations | -4.71M | -4.79M | -5.40M | -2.89M | -3.87M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 11.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 11.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 179.30K |
| Issuance of Common Stock | 8.50K | 800.00 | 56.46M | 0.00 | 5.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -39.30K | -116.10K | -292.80K |
| Cash from Financing | 8.50K | 800.00 | 56.42M | -116.10K | 5.74M |
| Foreign Exchange rate Adjustments | -37.30K | 28.10K | 500.00 | 12.70K | 5.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.74M | -4.76M | 51.04M | -2.99M | 1.88M |